Literature DB >> 23893268

Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3.

Anna Sellmer1, Jesper Vandborg Bjerre, Michael Rahbek Schmidt, Patrick J McNamara, Vibeke Elisabeth Hjortdal, Bente Høst, Bodil Hammer Bech, Tine Brink Henriksen.   

Abstract

OBJECTIVE: To assess the association between a patent ductus arteriosus (PDA) on day 3 of life and severe morbidity and mortality.
DESIGN: Cohort study.
SETTING: Neonatal Intensive Care Unit, Aarhus University Hospital, Denmark. PATIENTS: All neonates with a gestational age less than 32 weeks admitted from 2010 to 2012.
INTERVENTIONS: All neonates (n=183) were routinely screened with echocardiography for PDA on day 3 of life. Information on baseline characteristics and outcome was collected by structured coding sheets and medical records. MAIN OUTCOME MEASURES: The association among PDA diameter and pulmonary haemorrhage, intraventricular haemorrhage (IVH), necrotising enterocolitis, bronchopulmonary dysplasia (BPD), death, and the composite outcome of death or severe morbidity was assessed.
RESULTS: In neonates, born prior to 28 gestational weeks, a PDA on day 3 of life was associated with a threefold increase in odds of death or severe morbidity compared with neonates without PDA (OR=3.4; CI 1.1 to 11). The odds were highest in neonates with a large PDA (diameter ≥1.5 mm). Neonates with a large PDA were also found to have increased odds of IVH (OR 4.2; CI 1.3 to 14) and BPD (OR 3.7; CI 1.0 to 14) compared with neonates with no PDA.
CONCLUSIONS: In neonates born with a gestational age below 28 weeks the presence of a PDA on day 3 of life was associated with adverse outcome; this association was even more pronounced with a large PDA. Thus, early echocardiography may facilitate the identification of neonates suitable for a targeted approach to intervention in future randomised controlled trials.

Entities:  

Keywords:  Epidemiology; Neonatology

Mesh:

Year:  2013        PMID: 23893268     DOI: 10.1136/archdischild-2013-303816

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  40 in total

Review 1.  Neuroprotection from acute brain injury in preterm infants.

Authors:  Michelle Ryan; Thierry Lacaze-Masmonteil; Khorshid Mohammad
Journal:  Paediatr Child Health       Date:  2019-06-21       Impact factor: 2.253

2.  Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.

Authors:  Melissa Liebowitz; Ronald I Clyman
Journal:  J Pediatr       Date:  2017-04-07       Impact factor: 4.406

3.  CYP2C9*2 is associated with indomethacin treatment failure for patent ductus arteriosus.

Authors:  Sydney R Rooney; Elaine L Shelton; Ida Aka; Christian M Shaffer; Ronald I Clyman; John M Dagle; Kelli Ryckman; Tamorah R Lewis; Jeff Reese; Sara L Van Driest; Prince J Kannankeril
Journal:  Pharmacogenomics       Date:  2019-08       Impact factor: 2.533

4.  Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.

Authors:  Sarah Louise Harris; Kiran More; Bronwyn Dixon; Richard Troughton; Chris Pemberton; John Horwood; Nicola Ellis; Nicola Austin
Journal:  Eur J Pediatr       Date:  2018-01-19       Impact factor: 3.183

5.  Dual Therapy vs. Monotherapy for the Patent Ductus Arteriosus: A Systematic Review.

Authors:  Cathy Hammerman; Alona Bin-Nun; Haytham Abdaljalil; Itamar Nitzan; Yair Kasirer; Rawan Abu-Omar; Irina Schorrs; Francis Mimouni
Journal:  Pediatr Cardiol       Date:  2022-04-05       Impact factor: 1.655

6.  Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial.

Authors:  Ronald I Clyman; Joseph Kaempf; Melissa Liebowitz; Omer Erdeve; Ali Bulbul; Stellan Håkansson; Johanna Lindqvist; Aijaz Farooqi; Anup Katheria; Jason Sauberan; Jaideep Singh; Kelly Nelson; Andrea Wickremasinghe; Lawrence Dong; Denise C Hassinger; Susan W Aucott; Madoka Hayashi; Anne Marie Heuchan; William A Carey; Matthew Derrick; Erika Fernandez; Meera Sankar; Tina Leone; Jorge Perez; Arturo Serize
Journal:  J Pediatr       Date:  2020-10-28       Impact factor: 4.406

7.  Outcomes of Early Ligation of Patent Ductus Arteriosus in Preterms, Multicenter Experience.

Authors:  Mohamed H Ibrahim; Ahmed A Azab; Naglaa M Kamal; Mostafa A Salama; Hatem H Elshorbagy; Enas A A Abdallah; Abdulrahman Hammad; Laila M Sherief
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

8.  Persistent Ductus Arteriosus in Critically Ill Preterm Infants.

Authors:  Maria Livia Ognean; Oana Boantă; Simona Kovacs; Corina Zgârcea; Raluca Dumitra; Ecaterina Olariu; Doina Andreicuţ
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-11-08

9.  [B-type brain natriuretic peptide as marker of hemodynamic overload of the patent ductus arteriosus in the preterm infant].

Authors:  J Rafael Parra-Bravo; M Teresa Valdovinos-Ponce; Heladia García; Juan C Núñez-Enríquez; M Lourdes Jiménez-Cárdenas; Rodrigo Avilés-Monjaraz; Wendy Lavana-Hernández
Journal:  Arch Cardiol Mex       Date:  2020-11-03

10.  N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.

Authors:  Anna Sellmer; Vibeke Elisabeth Hjortdal; Jesper Vandborg Bjerre; Michael Rahbek Schmidt; Patrick J McNamara; Bodil Hammer Bech; Tine Brink Henriksen
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.